Overview

Cardiovascular disease (CVD) is the principal cause of death in patients with type 2 diabetes mellitus (T2DM) and the risk of CVD is two-threefold higher in patients with T2DM than in individuals without diabetes.1 Traditionally, cardiologists have not been routinely involved in the selection or management of glucose lowering therapies for patients with T2DM. However, results from recent T2DM cardiovascular outcome trials (CVOTs) with both SGLT2 inhibitors and GLP-1 receptor agonists are paradigm shifting in terms of their implications regarding CV benefits associated with specific glucose lowering agents.2-4 Management strategies for cardiovascular risk in patients with T2DM are rapidly evolving as data from CVOTs and real-world evidence from registries continues to emerge. The goal of this educational initiative is to examine recently published and emerging CVOT data for glucose lowering therapies, assess clinical implications of CVOT results on real-world T2DM treatment selection, and explore opportunities for cardiologists to partner with endocrinologists and primary care providers to improve cardiovascular outcomes in patients with diabetes.

1Di Angelantonio E, et al. JAMA. 2015. 2Zinman B, et al. N Engl J Med. 2015. 3Marso SP, et al; LEADER Trial Investigators. N Engl J Med. 2016. 4 Marso SP, et al; SUSTAIN-6 Investigators. N Engl J Med. 2016.

View All Speakers

Speakers

Silvio Inzucchi, MD



View Full Bio

Marc Sabatine, MD, MPH (Activity Chair)



View Full Bio

Adrian Hernandez, MD, MHS



View Full Bio

Accreditation

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine (ACCME)
CEC designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy (ACPE)
This knowledge-based activity is approved for 2.0 contact hour (.10 CEUs) of continuing pharmacy education credit (UAN JA0007101-0000-18-011-L01-P).

Nursing (ANCC)
This activity is designated for 2.0 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Physician Assistants (AAPA)
Creative Educational Concepts has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Upon completion of a CE request form, statements of credit for physicians, physician assistants, and nurses will be issued within 30 business days. Pharmacy credit will be reported directly to the National Association of Boards of Pharmacy® (NABP®) CPE Monitor electronic CE tracking system.

Acknowledgement

This activity is supported by an independent educational grant from AstraZeneca.

AHA Shuttle

SHUTTLE INFORMATION

Swissotel • Scientific Sessions Shuttle Bus Route #1 • Boards at McCormick Place Gate #3 Scientific Sessions shuttles from McCormick Place stop running at 7:30 PM